AUPH vs. BMY
Compare and contrast key facts about Aurinia Pharmaceuticals Inc. (AUPH) and Bristol-Myers Squibb Company (BMY).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: AUPH or BMY.
Correlation
The correlation between AUPH and BMY is 0.13, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
AUPH vs. BMY - Performance Comparison
Key characteristics
AUPH:
0.77
BMY:
0.60
AUPH:
1.50
BMY:
1.12
AUPH:
1.16
BMY:
1.14
AUPH:
0.40
BMY:
0.37
AUPH:
2.78
BMY:
1.51
AUPH:
12.19%
BMY:
11.61%
AUPH:
43.91%
BMY:
29.24%
AUPH:
-87.58%
BMY:
-70.62%
AUPH:
-76.33%
BMY:
-24.36%
Fundamentals
AUPH:
$1.13B
BMY:
$111.57B
AUPH:
-$0.15
BMY:
-$4.41
AUPH:
0.00
BMY:
1.21
AUPH:
$175.27M
BMY:
$48.30B
AUPH:
$152.57M
BMY:
$32.20B
AUPH:
$21.43M
BMY:
$3.16B
Returns By Period
In the year-to-date period, AUPH achieves a -12.81% return, which is significantly lower than BMY's -0.27% return. Over the past 10 years, AUPH has outperformed BMY with an annualized return of 7.98%, while BMY has yielded a comparatively lower 2.25% annualized return.
AUPH
-12.81%
1.29%
17.74%
36.41%
-17.47%
7.98%
BMY
-0.27%
-2.19%
19.78%
15.06%
0.36%
2.25%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
AUPH vs. BMY — Risk-Adjusted Performance Rank
AUPH
BMY
AUPH vs. BMY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Aurinia Pharmaceuticals Inc. (AUPH) and Bristol-Myers Squibb Company (BMY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
AUPH vs. BMY - Dividend Comparison
AUPH has not paid dividends to shareholders, while BMY's dividend yield for the trailing twelve months is around 4.34%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AUPH Aurinia Pharmaceuticals Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
BMY Bristol-Myers Squibb Company | 4.34% | 4.24% | 4.44% | 3.00% | 2.36% | 3.69% | 2.55% | 3.08% | 2.55% | 1.95% | 2.17% | 2.46% |
Drawdowns
AUPH vs. BMY - Drawdown Comparison
The maximum AUPH drawdown since its inception was -87.58%, which is greater than BMY's maximum drawdown of -70.62%. Use the drawdown chart below to compare losses from any high point for AUPH and BMY. For additional features, visit the drawdowns tool.
Volatility
AUPH vs. BMY - Volatility Comparison
Aurinia Pharmaceuticals Inc. (AUPH) has a higher volatility of 10.35% compared to Bristol-Myers Squibb Company (BMY) at 8.69%. This indicates that AUPH's price experiences larger fluctuations and is considered to be riskier than BMY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
AUPH vs. BMY - Financials Comparison
This section allows you to compare key financial metrics between Aurinia Pharmaceuticals Inc. and Bristol-Myers Squibb Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities